When Alexia Vernon was diagnosed with #DCIS, she was overwhelmed by the stories of women facing aggressive intervention. She yearned for a middle path. Her oncological surgeon, Janie Grumley, MD at Providence’s Margie Petersen Breast Center, sent her pathology from an excisional biopsy to PreludeDx. Alexia’s #DCISionRT score showed she had only a 3-5% chance of DCIS or invasive breast cancer recurrence over 10 years with breast-conserving surgery alone. This meant no radiation, no endocrine therapy and no mastectomy. “The results saved me from what could have been over-treatment,” says Alexia. https://bit.ly/4iHxZZX
Fractional Chief Learning Officer | Executive Coach | High-Stakes Communication & Presentation Skills Expert | Keynote Speaker | LinkedIn Learning Instructor | Thyroid & DCIS Breast Cancer Patient Advocate
4wThank you PreludeDx for highlighting my patient advocacy journey.